原发性肝癌经肝动脉升压化疗栓塞三年随访结果分析

Angiotensin Ⅱinfusion induced hypertension and chemoembolization for primary liver cancer-A clinical analysis of 85 cases with 3-year follow-up

自1992年5月至1993年4月，对85例原发性肝癌进行肝动脉血管紧张素Ⅱ介导的升压化疗栓塞（IHCE），三年随访结果1年生存率76．4％（65／85），2年生存率48．2％（41／85），3年生存率32．9％（28／85）。文中对IHCE治疗的机理进行探讨，并与TCE相比较。提出IHCE可取代TCE并作为不可切除肝癌的首选疗法。

Advanced primary liver cancer(PLC) was treated in 85 cases by Angiotensin Ⅱinfusion induced hypertension and chemoembolization (IHCE) from May 1992 to April 1993. 65 cases (76. 4% ) have survived more than 1 year, 41 cases (48. 2%) survived more than 2 years and 28 cases (32. 9 % ) more than 3 years. IHCE increases antitumor effect of TCE, can be the first choice for unresectable PLC .instead of TCE.